Lawyers for Pfizer are asking the Alabama Supreme Court to reconsider its recent decision that can hold name-brand drugmakers liable for the generic versions of their products, reports the Wall Street Journal. The company says the ruling violates the “basic legal tenet that a manufacturer is liable only for its products” and could make the state a “magnet for novel personal-injury lawsuits.”
New Faces Of Lawsuit Abuse Video: Louisiana Medical Professionals Highlight Problems with Trial Lawyer Advertising
Class Action Litigation, Medical Liability
Watch the Recording of ILR Briefly Live Event: COVID-19 State Liability Issues and Solutions
Foreign Corrupt Practices Act (FCPA), Medical Liability, Securities Litigation Reform, Telephone Consumer Protection Act (TCPA)
Plaintiffs' Lawyers Seething Over Push To Limit COVID-19 Related Medical Liability
Medical Liability
Protecting Doctors And Nurses On The Front Lines Of This Pandemic From Lawsuits
Medical Liability
In The News Today - April 17, 2020
Medical Liability
To sign up to receive our email with updates on Legal Reform, fill in the following fields. When you hit submit, you consent to our processing of the personal data you provide us with. Thanks and welcome.
Before submitting your personal data, please take a look at our Privacy Notice: General Privacy Notice orEU Privacy Notice. You can also contact us at privacy@uschamber.com.
